The chief executive of German industrial conglomerate Siemens AG last month stated emphatically that the company's Medical Engineering Group is not for sale. While Medical Engineering finished the first six months of the year in the red, due to a massive
The chief executive of German industrial conglomerate Siemens AG last month stated emphatically that the company's Medical Engineering Group is not for sale. While Medical Engineering finished the first six months of the year in the red, due to a massive restructuring program, Siemens president and CEO Heinrich Pierer said the division is not for sale.
Pierer's comments came with the release of Siemens revenue and earnings figures for the first half of 1997 (end-June). For the year to date, Medical Engineering recorded sales of 5.1 billion deutschmarks ($2.78 billion), up 2% compared with revenues of 5 billion DM ($2.72 billion) in the same period the year before. Siemens did not report the size of the loss at the division.
In statements accompanying the results, Pierer said that Siemens will not divest the Medical Engineering Group, although it is restructuring the business and is examining some of the operations in its portfolio, such as a dental unit in the group, that it intends to sell (SCAN 5/14/97). The moves may have sparked rumors that surfaced in the European press earlier this year that Siemens was looking to divest Medical Engineering. Nothing could be further from the truth, Pierer reiterated.
"Our Medical Engineering Group is not for sale," Pierer said. "It is an indispensable part of our core businesses. When we talk about adjusting portfolios in this or any other operating group-in this case the dental business-our goal is to optimize the entire group and is by no means a first step toward divestment."
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.